Literature DB >> 17034513

The role of neuropeptides in psoriasis.

R Saraceno1, C E Kleyn, G Terenghi, C E M Griffiths.   

Abstract

The pathogenesis of psoriasis is incompletely understood but cutaneous neurogenic inflammation is probably involved. This involvement is suggested by a number of clinical and histological observations. Reports about the distribution of cutaneous nerves and the quantification of nerve growth factor and neuropeptides, including calcitonin gene-related peptide and vasoactive intestinal peptide, in lesional and nonlesional psoriatic skin suggest that sensory neuropeptides contribute to the development of psoriasis. This review summarizes what is known about the role of neurogenic markers in psoriasis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17034513     DOI: 10.1111/j.1365-2133.2006.07518.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  37 in total

Review 1.  Mast cells and inflammation.

Authors:  Theoharis C Theoharides; Konstantinos-Dionysios Alysandratos; Asimenia Angelidou; Danae-Anastasia Delivanis; Nikolaos Sismanopoulos; Bodi Zhang; Shahrzad Asadi; Magdalini Vasiadi; Zuyi Weng; Alexandra Miniati; Dimitrios Kalogeromitros
Journal:  Biochim Biophys Acta       Date:  2010-12-23

2.  Serum neurotensin (NT) is increased in psoriasis and NT induces vascular endothelial growth factor release from human mast cells.

Authors:  M Vasiadi; A Therianou; K D Alysandratos; A Katsarou-Katsari; T Petrakopoulou; A Theoharides; E Papadavid; N Stavrianeas; C Antoniou; D Kalogeromitros; T C Theoharides
Journal:  Br J Dermatol       Date:  2012-05-14       Impact factor: 9.302

3.  Nerve growth factor: the dark side of the icon.

Authors:  Hubert Hondermarck
Journal:  Am J Pathol       Date:  2008-03-18       Impact factor: 4.307

4.  Chronic social stress Ameliorates psoriasiform dermatitis through upregulation of the Hypothalamic-Pituitary-Adrenal axis.

Authors:  Oscar Vegas; Brian Poligone; Paul Blackcloud; Elaine S Gilmore; JoAnne VanBuskirk; Christopher T Ritchlin; Alice P Pentland; Scott A Walter; Yasmine Nousari; Francisco Tausk
Journal:  Brain Behav Immun       Date:  2017-11-07       Impact factor: 7.217

5.  Inhibiting interleukin-18 production through the mitogen-activated protein kinase pathway, a potential role of corticotropin-releasing hormone in chronic plaque psoriasis.

Authors:  Chun-Lei Zhou; Xiao-Jing Yu; Da-Xing Cai; Yong-Hao Xu; Chun-Yang Li; Qing Sun
Journal:  Inflammation       Date:  2015       Impact factor: 4.092

Review 6.  Cytokines in psoriasis.

Authors:  Jaymie Baliwag; Drew H Barnes; Andrew Johnston
Journal:  Cytokine       Date:  2015-01-10       Impact factor: 3.861

Review 7.  Anti-interleukin and interleukin therapies for psoriasis: current evidence and clinical usefulness.

Authors:  Ya-Chu Tsai; Tsen-Fang Tsai
Journal:  Ther Adv Musculoskelet Dis       Date:  2017-11-06       Impact factor: 5.346

8.  Nociceptive Sensory Fibers Drive Interleukin-23 Production from CD301b+ Dermal Dendritic Cells and Drive Protective Cutaneous Immunity.

Authors:  Sakeen W Kashem; Maureen S Riedl; Chen Yao; Christopher N Honda; Lucy Vulchanova; Daniel H Kaplan
Journal:  Immunity       Date:  2015-09-15       Impact factor: 31.745

9.  Interleukin 33 and interleukin 4 regulate interleukin 31 gene expression and secretion from human laboratory of allergic diseases 2 mast cells stimulated by substance P and/or immunoglobulin E.

Authors:  Anastasia I Petra; Irene Tsilioni; Alexandra Taracanova; Alexandra Katsarou-Katsari; Theoharis C Theoharides
Journal:  Allergy Asthma Proc       Date:  2018-03-01       Impact factor: 2.587

10.  SP and IL-33 together markedly enhance TNF synthesis and secretion from human mast cells mediated by the interaction of their receptors.

Authors:  Alexandra Taracanova; Mihail Alevizos; Anna Karagkouni; Zuiy Weng; Errol Norwitz; Pio Conti; Susan E Leeman; Theoharis C Theoharides
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.